Compared to most other pediatric ALL with a 5-year survival of ~90%, MLL-rearranged (MLL-r) ALL has a particularly poor prognosis with 5-year survival of <40% 4-6. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.